C section News and Research

RSS

Leptin's fat-burning role in humans

For nearly a decade, scientists have known that leptin plays an important fat-burning role in humans. But the map of leptin's path through the body – the key to understanding how and why the hormone works – is still incomplete.

27 Jul 2004

Gene responsible for infertility

A paper describing discoveries about the role of a gene that is important in all animals, plants, and fungi is published in the 20 July 2004 issue of the journal Proceedings of the National Academy of Sciences.

23 Jul 2004

Gene associated with susceptibility to developing type 1 diabetes

A new gene mutation identified by researchers at Baylor College of Medicine in Houston is part of the constellation of genes associated with susceptibility to developing type 1 diabetes. It could also play a role in the devastating complications of diabetes such as kidney failure.

23 Jul 2004

New information guide on cervical cancer

Information and support charity CancerBACUP has launched an up-to-date guide to cervical cancer.

22 Jul 2004

Study to begin to develop patient guidelines for the use of antidepressant medications in pregnancy and following birth

The University of Arizona department of psychiatry is conducting a first-of-its kind study to begin to develop patient guidelines for the use of antidepressant medications in pregnancy and following birth.

21 Jul 2004

Will the insured sacrifice to help cover the uninsured? New study suggests the answer may be yes

One of the biggest questions facing Americans as the 2004 elections approach involves a tradeoff: Will those who currently have health insurance be willing to sacrifice in order to insure the 44 million people who don't?

21 Jul 2004

Unique dual laparoscopic surgical procedure

The skill and teamwork of two physicians at Scripps Clinic, combined with the expertise of the surgical staff at Scripps Green Hospital, recently led to a unique surgery that changed the life of a local woman.

21 Jul 2004

FDA is proposing to change the new and generic drug review process

The Food and Drug Administration (FDA) is proposing to change the new and generic drug review processes by replacing "approvable letters" and "not approvable letters" with "complete response letters" that provide companies with specific information about what needs to be done before their drugs can be approved for marketing.

20 Jul 2004

Report shows mixed results for lead screening rates in children

The New York State Attorney General Eliot Spitzer has released a report finding that certain Medicaid and Child Health Plus (CHP) managed care health plans have lead screening rates for infants and young children below the statewide average.

15 Jul 2004

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

An international team of scientists has identified an important molecular link involved in the spread – or metastasis – of melanoma to other organs such as the lungs.

15 Jul 2004

36.5 million people of working age have HIV

What's more, the ILO estimates that in the absence of increased access to treatment, the number of workers lost due to HIV/AIDS will have increased to 48 million by 2010 and 74 million by 2015, making HIV/AIDS one of the biggest causes of mortality in the world of work.

13 Jul 2004

HHS strengthen safeguards against mad cow disease

HHS Secretary Tommy G. Thompson and Agriculture Secretary Ann M. Veneman has announced three actions being taken to further strengthen existing safeguards that protect consumers against the agent that causes bovine spongiform encephalopathy (BSE, also known as “mad cow disease”).

10 Jul 2004

The structure of AGT shows how one human protein reduces the potency of chemotherapy

The fine details of this x-ray structure may help scientists find ways to fight certain cancers, such as brain tumors, which express high levels of AGT making them resistant to chemotherapy.

9 Jul 2004

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

A team of researchers led by The Burnham Institute’s Robert C. Liddington has determined the crystal structure of the binding complex between anthrax toxin and one of its host receptors.

8 Jul 2004